Insiders Indaptus Therapeutics, Inc.

Equities

INDP

US45339J1051

Delayed Nasdaq Other stock markets 12:54:48 2024-04-30 pm EDT			5-day change	1st Jan Change
2.142 ^USD	+0.95%		-13.98%	+21.70%

Mar. 14	Top Premarket Gainers	MT
Mar. 13	Indaptus Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Indaptus Therapeutics, Inc. Appoints Roger Waltzman as Its Chief Medical Officer, Effective August 7, 2023	23-08-08	CI
Indaptus Therapeutics’ Chief Scientific Officer Michael Newman, Ph.D. Named a Chair of the 4th STING & TLR-Targeting Therapies Summit	23-05-01	AQ
Indaptus Therapeutics, Inc. Announces Executive Changes	23-03-23	CI
Indaptus Therapeutics, Inc. Names Robert Martell, M.D., Ph.D. to Its Board of Directors	23-02-14	CI
Indaptus Therapeutics Announces Appointment of Boyan Litchev, M.D. as Chief Medical Officer, Effective January 31, 2022	22-01-03	CI
Indaptus Therapeutics, Inc. Announces Board of Director Changes	21-12-01	CI
Indaptus Therapeutics, Inc. Announces Management Changes	21-08-06	CI
Intec Pharma Ltd Announces Board Changes	21-06-22	CI
Intec Pharma Ltd Announces Resignation of Nadav Navon as Chief Operating Officer	21-02-08	CI
Intec Pharma Ltd. Announces Termination of Dr. R. Michael Gendreau as Chief Medical Officer, Effective on October 31, 2020	20-10-02	CI
Intec Pharma Appoints William Bradley Hayes to Board of Directors	18-06-29	CI
Intec Pharma LTD Appoints Roger J. Pomerantz as Board of Directors	18-03-26	CI
Intec Pharma Ltd. Names R. Michael Gendreau as Chief Medical Officer	18-01-31	CI
Intec Pharma, Ltd. Announces Changes to its Board of Directors	17-11-01	CI
Intec Pharma Ltd. Names Walt Linscott to the Position of Chief Administrative Officer	17-10-26	CI
Intec Pharma Ltd. Promotes Nadav Navon to Chief Operating Officer	17-07-27	CI
Intec Pharma Ltd. Appoints Jeffrey A. Meckler as Chief Executive Officer	17-07-10	CI
Intec Pharma Ltd. Announces Management Changes	17-05-03	CI
Intec Pharma Ltd. Appoints Jeffrey A. Meckler as Vice Chairman of its Board of Directors	17-04-09	CI
Intec Pharma Ltd. Nominates John W. Kozarich to Act as Chairman	16-05-16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Indaptus Therapeutics, Inc.

Equities

INDP

US45339J1051

Insiders

Filters